Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Terminated1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04525014Phase 1Terminated
RRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System Tumors
Brain Tumor, PediatricBrain Tumor, RecurrentCentral Nervous System Neoplasms+1 more
PrincipalinvestigatorStart date: 2023-01-26

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Bryan Oronsky, MD

EpicentRx, Inc.

Moderately Similar
4 trials

Shared therapeutic areas:

Brain Tumor, PediatricBrain Tumor, RecurrentCentral Nervous System Neoplasms+1 more

Worked with same sponsors:

EpicentRx, Inc.Texas Children's Cancer Center
Collaborated on 1 trial
Similarity Score44%

Maryam Fouladi

Children's Oncology Group

Related
5 trials

Shared therapeutic areas:

Unspecified Childhood Solid Tumor, Protocol Specific
Similarity Score8%

Roger J. Packer, MD

Children's National Research Institute

Related
5 trials

Shared therapeutic areas:

Central Nervous System Neoplasms
Similarity Score8%

Amar Gajjar, MD

St. Jude Children's Research Hospital

Related
10 trials

Shared therapeutic areas:

Central Nervous System Neoplasms
Similarity Score8%

Mark W. Kieran, MD, PhD

Dana-Farber Cancer Institute

Related
6 trials

Shared therapeutic areas:

Unspecified Childhood Solid Tumor, Protocol Specific
Similarity Score8%

Brigitte C. Widemann, MD

National Cancer Institute (NCI)

Related
6 trials

Shared therapeutic areas:

Unspecified Childhood Solid Tumor, Protocol Specific
Similarity Score8%

Martin J. van Den Bent, MD

Daniel Den Hoed Cancer Center at Erasmus Medical Center

Related
7 trials

Shared therapeutic areas:

Central Nervous System Neoplasms
Similarity Score8%

Steven Soignet, MD

Memorial Sloan Kettering Cancer Center

Related
6 trials

Shared therapeutic areas:

Unspecified Childhood Solid Tumor, Protocol Specific
Similarity Score8%

Marisa Couluris, DO

University of South Florida

Related
5 trials

Shared therapeutic areas:

Unspecified Childhood Solid Tumor, Protocol Specific
Similarity Score8%

Robert L. DeJager, MD, FACP

Daiichi Sankyo

Related
13 trials

Shared therapeutic areas:

Unspecified Childhood Solid Tumor, Protocol Specific
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04525014Phase 1PrincipalInvestigator

RRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System Tumors

Brain Tumor, PediatricBrain Tumor, RecurrentCentral Nervous System Neoplasms+1 more
Terminated

All 1 trials loaded